海外の治験の状況「1」での検索結果
10032件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Authorised
- A trial to assess the safety and efficacy of UX007 in patients with movement disorders associated with Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
- Glucose Transporter Type 1 deficiency syndrome MedDRA version: 19.1 Level: LLT Classification code 10061032 Term: Carbohydrate transport disorder System Organ Class: 100000004850 ;Therapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
- Australia, France, Germany, Ireland, Israel, Italy, Netherlands, Spain, United Kingdom, United States
- 2017-03-10
Not Recruiting
- A trial to assess the safety and efficacy of UX007 in patients with movement disorders associated with Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
- Glucose Transporter Type 1 deficiency syndrome MedDRA version: 20.0 Level: LLT Classification code 10061032 Term: Carbohydrate transport disorder System Organ Class: 100000004850 ;Therapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
- Australia, France, Germany, Israel, Italy, Spain, United Kingdom, United States
- 2017-03-01
Recruiting
- A Phase I Study of Recombinant Human Anti-PD-1 Monoclonal Antibody for Patients With Advanced Solid Tumors
- Tumor
- China
- 2018-01-12
Not recruiting
- A Study in Participants With Type 1 Diabetes Mellitus
- Diabetes Mellitus, Type 1;Diabetes Mellitus, Type 1;Diabetes Mellitus, Type 1
- Austria, France, Germany, Italy, Japan, Mexico, Poland, Russian Federation, United States
- 2011-11-28
Not recruiting
- This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
- Bipolar I Disorder;Bipolar I Disorder;Bipolar I Disorder;Bipolar I Disorder
- Argentina, Bulgaria, Chile, Czech Republic, France, Hungary, Japan, Poland, Russian Federation, Serbia, Slovakia, United States
- 2012-03-28
Not recruiting
- Safety and Efficacy Study of ELND005 as an Adjunctive Maintenance Treatment in Bipolar I Disorder
- Bipolar 1 Disorder;Bipolar 1 Disorder;Bipolar 1 Disorder;Bipolar 1 Disorder
- Bulgaria, Canada, Czech Republic, France, Lithuania, Poland, Romania, Spain, Turkey, United States
- 2012-08-24
Not recruiting
- Efficacy, Safety, and Tolerability of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Bipolar I Patients
- Bipolar I Disorder;Bipolar I Disorder;Bipolar I Disorder;Bipolar I Disorder
- Canada, Japan, Korea, Republic of, Poland, Romania, Taiwan, United States
- 2012-03-26
Not recruiting
- Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
- Bipolar I Disorder
- Bulgaria, Croatia, Romania, Russian Federation, Ukraine, United States
- 2011-07-14
Not recruiting
- Efficacy and Safety of Asenapine in the Prevention of Recurrence of Mood Episodes in Participants With Bipolar 1 Disorder (P06384)
- Bipolar 1 Disorder
- Bulgaria, Croatia, India, Philippines, Romania, Russian Federation, Serbia, Turkey, Ukraine, United States
- 2011-07-14
Not recruiting
- Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
- Bipolar I Disorder;Bipolar I Disorder;Bipolar I Disorder;Bipolar I Disorder
- Argentina, Australia, Bulgaria, Chile, Croatia, Czech Republic, Former Serbia and Montenegro, France, Hungary, India, Japan, Poland, Russian Federation, Serbia, Slovakia, United States
- 2011-05-19